Sequent Scientific Limited announced that at its board meeting held on August 25, 2020, approved the appointment of Dr. Kamal K Sharma and Mr. Milind Sarwate as an Independent Directors of the Company with effect from August 25, 2020 for a period of five consecutive years from the date of appointment and approved the resignation of Dr. Gopakumar Nair, Chairman and Independent Director of the Company effective immediately. Dr. Kamal K Sharma was also appointed as the Chairman of the Company while Mr. Milind Sarwate will head the Audit Committee. Both the appointments are expected to add value and weightage to the Board with their strategic management skills. Dr. Kamal Sharma is currently the non-executive Vice-Chairman of Lupin and has over 48 years of professional experience in executive positions in the Chemical and Pharmaceutical industries, and has essayed a wide variety of roles in operations, corporate development and executive management. Mr. Milind Sarwate is the Founder & CEO of Increate Value Advisors LLP and provides advice & mentorship in value creation, effective governance and capability building, leveraging his 37-year experience including long stints in Marico & Godrej.
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
SEQUENT SCIENTIFIC LIMITED 
